Live tape
Top 8, mentions 7d9,843TSLA2,036 mentions▲ +0.05GOOGL1,581 mentions▲ +0.04NVDA1,205 mentions▲ +0.07CRWV1,192 mentions▲ +0.03SPCX1,069 mentions▲ +0.07QQQ1,042 mentions▲ +0.04META873 mentions▲ +0.05NBIS845 mentions▲ +0.05

Equity · Healthcare

CELC

NASDAQ

Celcuity Inc.

$57 −5.60% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
63 sessions
$100 $40 21 Jul 16 Oct

The line runs $92 on 21 July through $57 on 16 October, on a scale from $40 to $100. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 21 Jul – 16 Oct 2026
Market cap $2.8B
52-week range $46 – $145
Avg volume 80.2K

as of Oct 16, 2026

CELC insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 7 Oct 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 5

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
07 Oct 2026 Furcht Leo Director Option exercise 250 $2K
01 Oct 2026 GRYSKA DAVID W Director Award 893
14 Aug 2026 Sullivan Brian F. Chief Executive Officer Award 80,000
14 Aug 2026 Laing Lance G. Chief Science Officer Award 20,000
14 Aug 2026 Hahne Vicky Chief Financial Officer Award 16,000

CELC reported financials

SEC EDGAR XBRL SEC EDGAR

CELC reported net income of −$177.0M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$177.0M 31 Dec 2025 fiscal year
Diluted EPS −$3.79 31 Dec 2025 fiscal year
Total assets $828.2M 30 Jun 2026 at period end
Total equity −$12.8M 30 Jun 2026 at period end

CELC earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$1.44 —
31 Mar 2026 Q1 2026 −$0.97 —
31 Dec 2025 FY 2025 −$3.79 —
30 Sep 2025 Q3 2025 −$0.92 —
30 Jun 2025 Q2 2025 −$1.04 —
31 Mar 2025 Q1 2025 −$0.86 —
31 Dec 2024 FY 2024 −$2.83 —
30 Sep 2024 Q3 2024 −$0.70 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CELC institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a CELC position for the quarter ended 30 Jun 2026 — a combined $929.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 7,915,792 $828.2M
Point72 Asset Management Added +132.2% shares 650,916 $68.1M
Marshall Wace Added +863.8% shares 182,156 $19.1M
Balyasny Asset Management Held (±25%) −10.4% shares 57,698 $6.0M
D. E. Shaw & Co. Added +46.7% shares 30,394 $3.2M
Man Group Trimmed −34.7% shares 28,845 $3.0M
AQR Capital Management Trimmed −29.2% shares 12,542 $1.3M
Fisher Asset Management New position 2,000 $209K
Citadel Advisors Exited
Millennium Management Exited

CELC fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 43 shares of CELC failed to deliver (about $3K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 43 $3K <0.001%
23 Sep 2026 786 $66K 0.002%
21 Sep 2026 335 $27K 0.001%
18 Sep 2026 1,220 $104K 0.002%
16 Sep 2026 7,975 $660K 0.016%
10 Sep 2026 31,638 $2.8M 0.065%
08 Sep 2026 31,865 $3.0M 0.065%
04 Sep 2026 780 $75K 0.002%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings